Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study.

Jordão HW, McKenna G, McMenamin ÚC, Kunzmann AT, Murray LJ, Coleman HG.

United European Gastroenterol J. 2019 Nov;7(9):1241-1249. doi: 10.1177/2050640619858043. Epub 2019 Jun 8.

2.

Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.

Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB.

Cancer. 2019 Sep 6. doi: 10.1002/cncr.32444. [Epub ahead of print]

PMID:
31490550
3.

Incidence and patterns of retropharyngeal lymph node involvement in oropharyngeal carcinoma.

Iyizoba-Ebozue Z, Murray LJ, Arunsingh M, Vaidyanathan S, Scarsbrook AF, Prestwich RJD.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33014-2. doi: 10.1016/j.radonc.2019.07.021. [Epub ahead of print]

PMID:
31431388
4.

Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.

Charles FG, Murray LJ, Giordano C, Spiess BD.

Can J Anaesth. 2019 Dec;66(12):1501-1513. doi: 10.1007/s12630-019-01449-x. Epub 2019 Jul 25.

PMID:
31346957
5.

Impact of choice of feeding tubes on long-term swallow function following chemoradiotherapy for oropharyngeal carcinoma.

Prestwich RJD, Murray LJ, Williams GF, Tease E, Taylor L, George C, Cardale K, Dyker KE, Murray P, Sen M, Ramasamy S.

Acta Oncol. 2019 Aug;58(8):1187-1196. doi: 10.1080/0284186X.2019.1609698. Epub 2019 Apr 29.

PMID:
31032694
6.

Isolation of chloride- and hydride-bridged tri-iron and -zinc clusters in a tris(β-oxo-δ-diimine) cyclophane ligand.

Hong DH, Knight BJ, Catalano VJ, Murray LJ.

Dalton Trans. 2019 Jul 2;48(26):9570-9575. doi: 10.1039/c9dt00799g.

PMID:
31012886
7.

Quality Assurance Peer Review of Head and Neck Contours in a Large Cancer Centre via a Weekly Meeting Approach.

Ramasamy S, Murray LJ, Cardale K, Dyker KE, Murray P, Sen M, Prestwich RJD.

Clin Oncol (R Coll Radiol). 2019 Jun;31(6):344-351. doi: 10.1016/j.clon.2019.03.001. Epub 2019 Mar 16.

PMID:
30890299
8.

Meningioma Screening With MRI in Childhood Leukemia Survivors Treated With Cranial Radiation.

Co JL, Swain M, Murray LJ, Ahmed S, Laperriere NJ, Tsang DS, Yu E, Pintilie M, Weiss J, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):640-643. doi: 10.1016/j.ijrobp.2019.02.057. Epub 2019 Mar 14.

PMID:
30880270
9.

Cyclophanes as Platforms for Reactive Multimetallic Complexes.

Ferreira RB, Murray LJ.

Acc Chem Res. 2019 Feb 19;52(2):447-455. doi: 10.1021/acs.accounts.8b00559. Epub 2019 Jan 22.

PMID:
30668108
10.

Catalytic Silylation of Dinitrogen by a Family of Triiron Complexes.

Ferreira RB, Cook BJ, Knight BJ, Catalano VJ, García-Serres R, Murray LJ.

ACS Catal. 2018 Aug 3;8(8):7208-7212. doi: 10.1021/acscatal.8b02021. Epub 2018 Jul 19.

11.

Chalcogen Impact on Covalency within Molecular [Cu33-E)]3+ Clusters (E = O, S, Se): A Synthetic, Spectroscopic, and Computational Study.

Cook BJ, Di Francesco GN, Ferreira RB, Lukens JT, Silberstein KE, Keegan BC, Catalano VJ, Lancaster KM, Shearer J, Murray LJ.

Inorg Chem. 2018 Sep 17;57(18):11382-11392. doi: 10.1021/acs.inorgchem.8b01000. Epub 2018 Aug 30.

12.

Predictors of return to work in survivors of critical illness.

Hodgson CL, Haines KJ, Bailey M, Barrett J, Bellomo R, Bucknall T, Gabbe BJ, Higgins AM, Iwashyna TJ, Hunt-Smith J, Murray LJ, Myles PS, Ponsford J, Pilcher D, Udy AA, Walker C, Young M, Jamie Cooper DJ; ICU-Recovery Investigators.

J Crit Care. 2018 Dec;48:21-25. doi: 10.1016/j.jcrc.2018.08.005. Epub 2018 Aug 13.

PMID:
30138904
13.

Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).

Murray LJ, Sykes J, Brierley J, Kim JJ, Wong RKS, Ringash J, Craig T, Velec M, Lindsay P, Knox JJ, Dawson LA.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):900-909. doi: 10.1016/j.ijrobp.2018.04.011. Epub 2018 Apr 12.

PMID:
29976502
14.

'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study.

van Putten M, Johnston BT, Murray LJ, Gavin AT, McManus DT, Bhat S, Turkington RC, Coleman HG.

United European Gastroenterol J. 2018 May;6(4):519-528. doi: 10.1177/2050640617737466. Epub 2017 Oct 11.

15.

A Tricopper(I) Complex Competent for O Atom Transfer, C-H Bond Activation, and Multiple O2 Activation Steps.

Cook BJ, Di Francesco GN, Kieber-Emmons MT, Murray LJ.

Inorg Chem. 2018 Sep 17;57(18):11361-11368. doi: 10.1021/acs.inorgchem.8b00921. Epub 2018 May 23.

PMID:
29791149
16.

Countercations and Solvent Influence CO2 Reduction to Oxalate by Chalcogen-Bridged Tricopper Cyclophanates.

Cook BJ, Di Francesco GN, Abboud KA, Murray LJ.

J Am Chem Soc. 2018 May 2;140(17):5696-5700. doi: 10.1021/jacs.8b02508. Epub 2018 Apr 20.

PMID:
29676578
17.

Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.

Chen H, Volgraf M, Do S, Kolesnikov A, Shore DG, Verma VA, Villemure E, Wang L, Chen Y, Hu B, Lu AJ, Wu G, Xu X, Yuen PW, Zhang Y, Erickson SD, Dahl M, Brotherton-Pleiss C, Tay S, Ly JQ, Murray LJ, Chen J, Amm D, Lange W, Hackos DH, Reese RM, Shields SD, Lyssikatos JP, Safina BS, Estrada AA.

J Med Chem. 2018 Apr 26;61(8):3641-3659. doi: 10.1021/acs.jmedchem.8b00117. Epub 2018 Apr 12.

PMID:
29590749
18.

Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.

Mc Menamin ÚC, Kunzmann AT, Cook MB, Johnston BT, Murray LJ, Spence AD, Cantwell MM, Cardwell CR.

Int J Cancer. 2018 Aug 15;143(4):831-841. doi: 10.1002/ijc.31375. Epub 2018 Mar 30.

19.

Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study.

Gray RT, Coleman HG, Hughes C, Murray LJ, Cardwell CR.

BMC Cancer. 2018 Feb 27;18(1):228. doi: 10.1186/s12885-018-4142-y.

20.

Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.

Spence AD, Busby J, Murchie P, Kunzmann AT, McMenamin ÚC, Coleman HG, Johnston BT, O'Rorke MA, Murray LJ, Iversen L, Lee AJ, Cardwell CR.

Int J Cancer. 2018 Jul 1;143(1):22-31. doi: 10.1002/ijc.31293. Epub 2018 Mar 8.

21.

Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.

Petrick JL, Falk RT, Hyland PL, Caron P, Pfeiffer RM, Wood SN, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA, Cook MB.

PLoS One. 2018 Jan 17;13(1):e0190325. doi: 10.1371/journal.pone.0190325. eCollection 2018.

22.

Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.

Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, Coleman HG.

BMC Gastroenterol. 2017 Dec 11;17(1):157. doi: 10.1186/s12876-017-0708-4. Review.

23.

QuPath: Open source software for digital pathology image analysis.

Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW.

Sci Rep. 2017 Dec 4;7(1):16878. doi: 10.1038/s41598-017-17204-5.

24.

Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review.

Kunzmann AT, McMenamin ÚC, Spence AD, Gray RT, Murray LJ, Turkington RC, Coleman HG.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):263-273. doi: 10.1097/MEG.0000000000001029. Review.

PMID:
29189391
25.

Correction to: The effectiveness of a life style modification and peer support home blood pressure monitoring in control of hypertension: protocol for a cluster randomized controlled trial.

Su TT, Majid HA, Nahar AM, Azizan NA, Hairi FM, Thangiah N, Dahlui M, Bulgiba A, Murray LJ.

BMC Public Health. 2017 Nov 6;17(1):864. doi: 10.1186/s12889-017-4862-y.

26.

Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.

Murray LJ, Lilley J, Hawkins MA, Henry AM, Dickinson P, Sebag-Montefiore D.

Radiother Oncol. 2017 Nov;125(2):213-222. doi: 10.1016/j.radonc.2017.09.030. Epub 2017 Oct 21. Review.

27.

Correlating Bridging Ligand with Properties of Ligand-Templated [MnII3X3]3+ Clusters (X = Br-, Cl-, H-, MeO-).

Anderton KJ, Ermert DM, Quintero PA, Turvey MW, Fataftah MS, Abboud KA, Meisel MW, Čižmár E, Murray LJ.

Inorg Chem. 2017 Oct 2;56(19):12012-12022. doi: 10.1021/acs.inorgchem.7b02004. Epub 2017 Sep 18.

PMID:
28920698
28.

Erratum to: The impact of disability in survivors of critical illness.

Hodgson CL, Udy AA, Bailey M, Barrett J, Bellomo R, Bucknall T, Gabbe BJ, Higgins AM, Iwashyna TJ, Hunt-Smith J, Murray LJ, Myles PS, Ponsford J, Pilcher D, Walker C, Young M, Cooper DJ.

Intensive Care Med. 2017 Dec;43(12):1938. doi: 10.1007/s00134-017-4937-3.

PMID:
28916987
29.

Commonly used medications and endometrial cancer survival: a population-based cohort study.

Sanni OB, Mc Menamin ÚC, Cardwell CR, Sharp L, Murray LJ, Coleman HG.

Br J Cancer. 2017 Jul 25;117(3):432-438. doi: 10.1038/bjc.2017.207. Epub 2017 Jul 6.

30.

Reactivity of hydride bridges in a high-spin [Fe3(μ-H)3]3+ cluster: reversible H2/CO exchange and Fe-H/B-F bond metathesis.

Anderton KJ, Knight BJ, Rheingold AL, Abboud KA, García-Serres R, Murray LJ.

Chem Sci. 2017 May 1;8(5):4123-4129. doi: 10.1039/c6sc05583d. Epub 2017 Apr 11.

31.

Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.

Murray LJ, Dawson LA.

Semin Radiat Oncol. 2017 Jul;27(3):247-255. doi: 10.1016/j.semradonc.2017.02.002. Epub 2017 Feb 20. Review.

PMID:
28577832
32.

Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.

Shivappa N, Hebert JR, Anderson LA, Shrubsole MJ, Murray LJ, Getty LB, Coleman HG.

Br J Nutr. 2017 May;117(9):1323-1331. doi: 10.1017/S0007114517001131. Epub 2017 Jun 2.

PMID:
28571591
33.

The impact of disability in survivors of critical illness.

Hodgson CL, Udy AA, Bailey M, Barrett J, Bellomo R, Bucknall T, Gabbe BJ, Higgins AM, Iwashyna TJ, Hunt-Smith J, Murray LJ, Myles PS, Ponsford J, Pilcher D, Walker C, Young M, Cooper DJ.

Intensive Care Med. 2017 Jul;43(7):992-1001. doi: 10.1007/s00134-017-4830-0. Epub 2017 May 22. Erratum in: Intensive Care Med. 2017 Sep 15;:.

PMID:
28534110
34.

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.

Gray RT, Loughrey MB, Bankhead P, Cardwell CR, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ, Coleman HG.

Br J Cancer. 2017 Jun 6;116(12):1652-1659. doi: 10.1038/bjc.2017.139. Epub 2017 May 18.

35.

Statin use after esophageal cancer diagnosis and survival: A population based cohort study.

Cardwell CR, Spence AD, Hughes CM, Murray LJ.

Cancer Epidemiol. 2017 Jun;48:124-130. doi: 10.1016/j.canep.2017.04.015. Epub 2017 May 6.

PMID:
28486205
36.

Lack of effectiveness of routine clinic and blood test-based follow-up for diffuse large B cell lymphoma.

Chasty B, Patterson M, Murray LJ, Johnson R, Thomas E, Gilson D, Burton C, Prestwich RJD.

Br J Haematol. 2018 Jul;182(1):138-140. doi: 10.1111/bjh.14745. Epub 2017 May 9. No abstract available.

37.

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.

Gray RT, Cantwell MM, Coleman HG, Loughrey MB, Bankhead P, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, Cardwell CR, Johnston BT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ.

Clin Transl Gastroenterol. 2017 Apr 27;8(4):e91. doi: 10.1038/ctg.2017.18.

38.

Oral bisphosphonates and colorectal cancer.

Vogtmann E, Corley DA, Almers LM, Cardwell CR, Murray LJ, Abnet CC.

Sci Rep. 2017 Mar 10;7:44177. doi: 10.1038/srep44177.

39.

Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study.

Cook MB, Wood S, Hyland PL, Caron P, Drahos J, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA.

Andrology. 2017 Mar;5(2):240-247. doi: 10.1111/andr.12314. Epub 2017 Feb 27.

40.

Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.

Mc Menamin ÚC, Cardwell CR, Hughes CM, Murray LJ.

Cancer Epidemiol. 2017 Apr;47:20-27. doi: 10.1016/j.canep.2016.12.008. Epub 2017 Jan 12.

PMID:
28088656
41.

Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.

Cardwell CR, Pottegård A, Vaes E, Garmo H, Murray LJ, Brown C, Vissers PA, O'Rorke M, Visvanathan K, Cronin-Fenton D, De Schutter H, Lambe M, Powe DG, van Herk-Sukel MP, Gavin A, Friis S, Sharp L, Bennett K.

Breast Cancer Res. 2016 Dec 1;18(1):119.

42.

Cardiac glycosides and breast cancer risk: A systematic review and meta-analysis of observational studies.

Karasneh RA, Murray LJ, Cardwell CR.

Int J Cancer. 2017 Mar 1;140(5):1035-1041. doi: 10.1002/ijc.30520. Epub 2016 Nov 27. Review.

43.

Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.

Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA.

Am J Gastroenterol. 2016 Nov;111(11):1528-1535. doi: 10.1038/ajg.2016.348. Epub 2016 Aug 30.

44.

Statin use and survival in colorectal cancer: Results from a population-based cohort study and an updated systematic review and meta-analysis.

Gray RT, Coleman HG, Hughes C, Murray LJ, Cardwell CR.

Cancer Epidemiol. 2016 Dec;45:71-81. doi: 10.1016/j.canep.2016.10.004. Epub 2016 Oct 14. Review.

PMID:
27750068
45.

Statin use and breast cancer survival: a nationwide cohort study in Scotland.

Mc Menamin ÚC, Murray LJ, Hughes CM, Cardwell CR.

BMC Cancer. 2016 Aug 4;16:600. doi: 10.1186/s12885-016-2651-0.

46.

Insights into small molecule activation by multinuclear first-row transition metal cyclophanates.

Ermert DM, Murray LJ.

Dalton Trans. 2016 Oct 7;45(37):14499-507. doi: 10.1039/c6dt01857b. Epub 2016 Jul 21.

PMID:
27439696
47.

Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.

Wennerström EC, Risques RA, Prunkard D, Giffen C, Corley DA, Murray LJ, Whiteman DC, Wu AH, Bernstein L, Ye W, Chow WH, Vaughan TL, Liao LM.

Cancer Med. 2016 Sep;5(9):2657-65. doi: 10.1002/cam4.810. Epub 2016 Jul 6.

48.

A three-coordinate Fe(ii) center within a [3Fe-(μ3-S)] cluster that provides an accessible coordination site.

Lee Y, Abboud KA, García-Serres R, Murray LJ.

Chem Commun (Camb). 2016 Jul 28;52(59):9295-8. doi: 10.1039/c6cc04671a. Epub 2016 Jul 1.

PMID:
27363672
49.

Synthesis and evaluation of a series of 4-azaindole-containing p21-activated kinase-1 inhibitors.

Lee W, Crawford JJ, Aliagas I, Murray LJ, Tay S, Wang W, Heise CE, Hoeflich KP, La H, Mathieu S, Mintzer R, Ramaswamy S, Rouge L, Rudolph J.

Bioorg Med Chem Lett. 2016 Aug 1;26(15):3518-24. doi: 10.1016/j.bmcl.2016.06.031. Epub 2016 Jun 15.

PMID:
27346791
50.

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.

Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1412-1419.e3. doi: 10.1016/j.cgh.2016.05.032. Epub 2016 Jun 2.

Supplemental Content

Loading ...
Support Center